UPDATE: Jefferies Starts Moonlake Immunotherapeutics (MLTX) at Buy
Tweet Send to a Friend
(Updated - November 11, 2022 8:08 AM EST)
Jefferies analyst Kelly Shi initiates coverage on Moonlake Immunotherapeutics (NASDAQ: MLTX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Kelly Shi initiates coverage on Moonlake Immunotherapeutics (NASDAQ: MLTX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
